Jemincare
Clinical trials sponsored by Jemincare, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug interaction study launches for polycystic kidney disease treatment Results expected Nov 2026 (estimated)
- New shot could tame stubborn hives when pills fail Results expected Jun 2027 (estimated)
- New allergy shot for teens enters early safety testing Results expected Jul 2027 (estimated)
-
New shot could tame stubborn hives when pills fail
Disease control Recruiting nowThis study tests an injection called JYB1904 in 180 adults with chronic spontaneous urticaria (hives and itching lasting over 6 weeks) that isn't well controlled by standard antihistamines. Participants receive either the drug or a placebo every 12 weeks for 48 weeks. The main go…
Phase 3 • Sponsor: Jemincare • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis early-phase study tests an experimental tablet, JMKX005425, in people with advanced solid tumors that have high microsatellite instability or mismatch repair deficiency. The main goals are to check the drug's safety and find the right dose. About 102 participants will take t…
Phase 1 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC